56.25 USD
0.43
0.76%
Last update Dec 15, 3:59 PM EST
Pre-market
Day range
55.65000
58.35000
Previous close
56.68000
Open
57.12000
Access this stock data via API
Subscribe
Crispr Therapeutics AG
56.25
0.43
0.76%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 35M
Cost of revenue 57.1M 45.2M 57.5M 0
Gross profit -57.1M -45.2M -57.5M 35M
Operating expense
Research & development 58.9M 166.1M 72.5M 82.2M
Selling general and admin 16.9M 18.9M 19.3M 18.1M
Other operating expenses -889K -892K -865K -691K
Operating income -132.1M -229.3M -148.4M -64.6M
Non operating interest income
Income
Expense
Other income expense 26.2M 22.1M 13.5M 28.0M
Pretax income -105.8M -207.3M -134.9M -36.6M
Tax provision 619K 1.3M 1.1M 700K
Net income -106.4M -208.5M -136.0M -37.3M
Basic EPS -1.2 -2.4 -1.6 -0.4
Diluted EPS -1.2 -2.4 -1.6 -0.4
Basic average shares 91.3M 87.1M 85.9M 85.5M
Diluted average shares 91.3M 87.1M 85.9M 85.5M
EBITDA -127.6M -224.7M -143.7M -59.7M
Net income from continuing op. -106.4M -208.5M -136.0M -37.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 3 hours 25 minutes

06:04
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).